Niagen Bioscience (NAGE) Raw Materials (2018 - 2019)
Niagen Bioscience (NAGE) reported Raw Materials of $1.4 million for Q4 2019, down 39.49% year-over-year from $2.3 million in Q4 2018, and down 39.49% quarter-over-quarter from $2.3 million in Q4 2018.
Niagen Bioscience (NAGE) Raw Materials (2018 - 2019) Analysis & Trends
Niagen Bioscience (NAGE) has 2 years of Raw Materials data on file, last reported at $1.4 million in Q4 2019.
- Raw Materials for Q4 2019 came in at $1.4 million, down 39.49% year-over-year; the trailing twelve-month figure through Dec 2019 was $1.4 million (down 39.49% YoY), and the FY2019 annual result was $1.4 million, down 39.49% from the prior year.
- Raw Materials declined to $1.4 million in Q4 2019 per NAGE's latest filing, from $2.3 million in the prior quarter.
- Over five years, Raw Materials peaked at $2.3 million in Q4 2018 and troughed at $1.4 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Niagen Bioscience | 269.32 Mn | 202.77 Mn | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 1.36 Mn |
| Dec 31, 2018 | 2.25 Mn |